{"id":"https://openalex.org/W2075667178","doi":"https://doi.org/10.1097/00002371-200405000-00008","title":"Safety, Pharmacokinetics, and Biological Pharmacodynamics of the Immunocytokine EMD 273066 (huKS-IL2)","display_name":"Safety, Pharmacokinetics, and Biological Pharmacodynamics of the Immunocytokine EMD 273066 (huKS-IL2)","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W2075667178","doi":"https://doi.org/10.1097/00002371-200405000-00008","mag":"2075667178","pmid":"https://pubmed.ncbi.nlm.nih.gov/15076141"},"language":"en","primary_location":{"id":"doi:10.1097/00002371-200405000-00008","doi":"https://doi.org/10.1097/00002371-200405000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002371-200405000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109416216","display_name":"Yoo\u2010Joung Ko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yoo-Joung Ko","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA, USA","Beth Israel Deaconess Medical Center, Boston, MA","EMD-Lexigen Research Center Corp., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"EMD-Lexigen Research Center Corp., Billerica, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043769628","display_name":"Glenn J. Bubley","orcid":"https://orcid.org/0000-0002-3062-643X","observed_orcids":["https://orcid.org/0000-0002-3062-643X"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Glenn J. Bubley","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA","EMD-Lexigen Research Center Corp., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"EMD-Lexigen Research Center Corp., Billerica, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110567044","display_name":"Robert W. Weber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799594305","display_name":"Saint Francis Memorial Hospital","ror":"https://ror.org/05h29d328","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799594305","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Weber","raw_affiliation_strings":["Saint Francis Memorial Hospital, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Saint Francis Memorial Hospital, San Francisco, CA","institution_ids":["https://openalex.org/I2799594305"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087064759","display_name":"Charles H. Redfern","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles Redfern","raw_affiliation_strings":["Sharp Clinical Oncology Research, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sharp Clinical Oncology Research, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109856406","display_name":"Daniel P. Gold","orcid":"https://orcid.org/0000-0001-6184-5494","observed_orcids":["https://orcid.org/0000-0001-6184-5494"]},"institutions":[{"id":"https://openalex.org/I4210106595","display_name":"Sidney Kimmel Cancer Center","ror":"https://ror.org/010h6g454","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel P. Gold","raw_affiliation_strings":["Sidney Kimmel Cancer Center, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Cancer Center, San Diego, CA","institution_ids":["https://openalex.org/I4210106595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110340788","display_name":"Lothar H. Finke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lothar Finke","raw_affiliation_strings":["EMD Pharmaceuticals Inc., Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Pharmaceuticals Inc., Durham, NC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109163156","display_name":"Andreas Kovar","orcid":"https://orcid.org/0000-0002-1681-8312","observed_orcids":["https://orcid.org/0000-0002-1681-8312"]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Kovar","raw_affiliation_strings":["Merck KGaA, Darmstadt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck KGaA, Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005350858","display_name":"Thomas A. Dahl","orcid":"https://orcid.org/0000-0003-4642-4346","observed_orcids":["https://orcid.org/0000-0003-4642-4346"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Thomas Dahl","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA","EMD-Lexigen Research Center Corp., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"EMD-Lexigen Research Center Corp., Billerica, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000263428","display_name":"Stephen D. Gillies","orcid":"https://orcid.org/0000-0002-2080-4220","observed_orcids":["https://orcid.org/0000-0002-2080-4220"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen D. Gillies","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA","EMD-Lexigen Research Center Corp., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"EMD-Lexigen Research Center Corp., Billerica, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5000263428","https://openalex.org/A5005350858","https://openalex.org/A5043769628","https://openalex.org/A5109416216"],"corresponding_institution_ids":["https://openalex.org/I1316535847"],"apc_list":null,"apc_paid":null,"fwci":3.8639,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.93457378,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"27","issue":"3","first_page":"232","last_page":"239"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.02459999918937683,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunocytokines","display_name":"immunocytokines","score":0.9330000281333923},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9470000267028809},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9039999842643738},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8939999938011169},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9710000157356262},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.6330000162124634},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7139999866485596},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.8740000128746033},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9120000004768372},{"id":"https://openalex.org/keywords/lymphocyte-count","display_name":"lymphocyte count","score":0.7200000286102295}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.8011410236358643},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7948282361030579},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7394819259643555},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7249676585197449},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5238747000694275},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.4657512307167053},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46555429697036743},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4049697518348694},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31849798560142517}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008214","descriptor_name":"Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013696","descriptor_name":"Temperature","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002371-200405000-00008","doi":"https://doi.org/10.1097/00002371-200405000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002371-200405000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},{"id":"pmid:15076141","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15076141","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunotherapy (Hagerstown, Md. : 1997)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W70059979","https://openalex.org/W1570734769","https://openalex.org/W1786821161","https://openalex.org/W1950572133","https://openalex.org/W1966204823","https://openalex.org/W1973724116","https://openalex.org/W1975568557","https://openalex.org/W1981743199","https://openalex.org/W2005112283","https://openalex.org/W2018323373","https://openalex.org/W2022565486","https://openalex.org/W2049020751","https://openalex.org/W2065830732","https://openalex.org/W2090242584","https://openalex.org/W2099578238","https://openalex.org/W2123914905","https://openalex.org/W2124446900","https://openalex.org/W2141086589","https://openalex.org/W2144642146","https://openalex.org/W2169355589","https://openalex.org/W2186456488","https://openalex.org/W2245454598","https://openalex.org/W2277257507","https://openalex.org/W2330612110"],"related_works":["https://openalex.org/W2589489383","https://openalex.org/W2139837928","https://openalex.org/W2062080828","https://openalex.org/W2106497182","https://openalex.org/W2282056056","https://openalex.org/W3148342899","https://openalex.org/W3008651065","https://openalex.org/W2253858448","https://openalex.org/W4379283404","https://openalex.org/W2070843905"],"abstract_inverted_index":{"This":[0],"phase":[1],"1":[2,239],"clinical":[3],"trial":[4],"was":[5,47,117,122,234,236,246],"conducted":[6],"to":[7,12,27,127,253],"evaluate":[8],"the":[9,14,20,92,144,153,185,267,274],"safety":[10],"and":[11,33,178,189,222,225],"determine":[13],"maximum":[15],"tolerated":[16,125,281],"dose":[17,63,99,129,187],"(MTD)":[18],"of":[19,56,80,86,94,111,130,175,199,248,287],"immunocytokine":[21,276],"EMD":[22,45,95,120,170,206,277],"273066":[23,46,96,121,171,207,278],"huKS-IL2":[24],"and,":[25],"secondarily,":[26],"assess":[28],"its":[29],"pharmacokinetics,":[30],"immunogenic":[31],"potential,":[32],"immunologic":[34,209],"activity":[35,210,291],"in":[36,49,107,113,152,215,292],"patients":[37,81,112,151,162,293],"with":[38,164,262,294],"androgen-independent":[39,295],"prostate":[40,296],"cancer":[41],"(n":[42],"=":[43],"22).":[44],"administered":[48],"3-day":[50],"cycles":[51],"(separated":[52],"by":[53,65,213],"4":[54],"weeks)":[55],"once-daily,":[57],"4-hour":[58],"intravenous":[59],"infusions":[60],"at":[61,108,282],"a":[62,83,114,128,196,285],"determined":[64],"an":[66],"escalation":[67],"protocol":[68],"(0.4,":[69],"0.7,":[70],"1.4,":[71],"2.8,":[72,165],"4.3,":[73],"6.4,":[74,166],"or":[75,157,167,192],"8.5":[76,168],"mg/m/d).":[77],"Approximately":[78],"2/3":[79],"received":[82],"second":[84,197],"cycle":[85,188],"treatment.":[87,200],"The":[88],"results":[89],"show":[90],"that":[91,102,273],"MTD":[93],"[ie,":[97],"one":[98],"level":[100,286],"below":[101],"producing":[103],"dose-limiting":[104],"toxicity":[105],"(DLT)":[106],"least":[109],"33%":[110],"dosing":[115,159],"group]":[116],"6.4":[118],"mg/m/d.":[119,132],"generally":[123],"well":[124,280],"up":[126],"4.3":[131],"No":[133,201],"DLTs,":[134],"defined":[135],"as":[136,211],"drug-related":[137],"toxicities":[138],">OR=":[139],"Grade":[140],"3":[141],"occurring":[142],"during":[143,195],"first":[145,186],"treatment":[146],"cycle,":[147],"were":[148,182,204],"observed":[149,183,288],"among":[150],"0.4-,":[154],"0.7-,":[155],"1.4-,":[156],"4.3-mg/m/d":[158],"groups.":[160],"Four":[161],"treated":[163],"mg/m/d":[169],"experienced":[172],"DLTs.":[173],"Titers":[174],"both":[176],"antiimmunocytokine":[177],"anti-FcIL-2":[179],"antibody":[180],"responses":[181],"after":[184,241],"either":[190],"decreased":[191],"remained":[193],"stable":[194],"course":[198],"hypersensitivity":[202],"reactions":[203],"observed.":[205],"exhibited":[208],"demonstrated":[212],"increases":[214],"lymphocyte":[216],"counts,":[217],"natural":[218],"killer":[219],"cell":[220],"number":[221],"specific":[223],"activity,":[224],"antibody-dependent":[226],"cellular":[227],"cytotoxicity":[228],"activity.":[229],"On":[230],"average,":[231],"Cmax,":[232],"which":[233,245],"dose-dependent,":[235],"achieved":[237],"within":[238],"hour":[240],"infusion.":[242],"Mean":[243],"t(1/2)":[244],"independent":[247],"dose,":[249],"ranged":[250],"from":[251],"4.0":[252],"6.7":[254],"hours":[255],"across":[256],"doses.":[257],"A":[258],"zero-compartment":[259],"body":[260],"model":[261],"one-order":[263],"kinetics":[264],"best":[265],"described":[266],"concentration-time":[268],"profiles.":[269],"These":[270],"data":[271],"demonstrate":[272],"novel":[275],"is":[279],"doses":[283],"above":[284],"systemic":[289],"biologic":[290],"cancer.":[297]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}